Clinical Trial Update: XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing XELOX and XELIRI regimens as first-line treatment for advanced colorectal cancer. Current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Harbin Medical University | Conditions: Colorectal Neoplasms, Chemotherapy | Phase 2 | Status: UNKNOWN